Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „ruxolitinib“
Suchtreffer
Begriffe & Kennungen
Jakavi · 4.5 · 10 Dual CYP2C9 and CYP3A4 inhibitors In healthy subjects co-administration of ruxolitinib (10 mg single dose)
Eintrag öffnenJakavi · 4.5 · A study in healthy subjects indicated that ruxolitinib did not inhibit the metabolism of the oral CYP3A4 subst
Eintrag öffnenJakavi · 4.5 · A study in healthy subjects indicated that ruxolitinib did not inhibit the metabolism of the oral CYP3A4 subst
Eintrag öffnenJakavi · 4.5 · Dual CYP2C9 and CYP3A4 inhibitors In healthy subjects co-administration of ruxolitinib (10 mg single dose) wit
Eintrag öffnenJakavi · 4.5 · Effects of ruxolitinib on other medicinal products
Eintrag öffnenJakavi · 4.5 · Effects of ruxolitinib on other medicinal products
Eintrag öffnenJakavi · 4.5 · In healthy subjects given ruxolitinib (50 mg single dose) following the potent CYP3A4 inducer rifampicin (600
Eintrag öffnenJakavi · 4.5 · In healthy subjects given ruxolitinib (50 mg single dose) following the potent CYP3A4 inducer rifampicin (600
Eintrag öffnenJakavi · 4.5 · Interactions resulting in dose reduction of ruxolitinib
Eintrag öffnenJakavi · 4.5 · Interactions resulting in dose reduction of ruxolitinib
Eintrag öffnenJakavi · 4.5 · No dose adjustment is recommended when ruxolitinib is co-administered with mild or moderate CYP3A4 inhibitors
Eintrag öffnenJakavi · 4.5 · No dose adjustment is recommended when ruxolitinib is co-administered with mild or moderate CYP3A4 inhibitors
Eintrag öffnenJakavi · 4.5 · Other interactions to be considered affecting ruxolitinib
Eintrag öffnenJakavi · 4.5 · Other interactions to be considered affecting ruxolitinib
Eintrag öffnenJakavi · 4.5 · Ruxolitinib is eliminated through metabolism catalysed by CYP3A4 and CYP2C9. Thus, medicinal products inhibiti
Eintrag öffnenJakavi · 4.5 · Ruxolitinib is eliminated through metabolism catalysed by CYP3A4 and CYP2C9. Thus, medicinal products inhibiti
Eintrag öffnenJakavi · 4.5 · Substances transported by P-glycoprotein or other transporters Ruxolitinib may inhibit P-glycoprotein and brea
Eintrag öffnenJakavi · 4.5 · Substances transported by P-glycoprotein or other transporters Ruxolitinib may inhibit P-glycoprotein and brea
Eintrag öffnenJakavi · 4.5 · When administering ruxolitinib with strong CYP3A4 inhibitors the unit dose of ruxolitinib should be reduced by
Eintrag öffnenJakavi · 4.5 · When administering ruxolitinib with strong CYP3A4 inhibitors the unit dose of ruxolitinib should be reduced by
Eintrag öffnen